Employment Verification
for ImClone Systems.
Fast, secure, and automated employment verification for ImClone Systems employees.
$39.99 per verification
Pay only when it worksAbout ImClone Systems
ImClone Systems was an American biopharmaceutical company founded in 1984, specializing in the development and commercialization of oncology treatments. The company gained prominence through its development of Erbitux (cetuximab), a monoclonal antibody used to treat certain types of colorectal cancer and head and neck cancer. The company became publicly traded in 1991 on the NASDAQ exchange. ImClone Systems faced significant controversy in 2001 when its CEO Samuel D. Waksal was involved in an insider trading scandal, along with Martha Stewart, leading to both their convictions and imprisonments. Despite the controversy, ImClone’s scientific achievements continued, particularly with Erbitux, which received FDA approval in 2004. The drug became a significant commercial success, generating substantial revenue through partnerships with Bristol-Myers Squibb in North America and Merck KGaA in Europe. In 2008, Eli Lilly and Company acquired ImClone Systems for $6.5 billion, making it a fully owned subsidiary. The acquisition strengthened Eli Lilly’s oncology portfolio and research capabilities. Under Eli Lilly’s ownership, ImClone’s research facilities continued to operate, focusing on the development of new cancer therapeutics and expanding the applications of existing treatments.
The information on this page is not an endorsement of Truv’s services by ImClone Systems and is meant to be purely informational.
Verify ImClone Systems Employees
- Fast and automated verification: Most employment and income verifications are completed in under 24 hours.
- Secure and reliable: Truv is SOC2 TYPEII Compliant. Certified for Fannie Mae’s Day 1 Certainty® and Freddie Mac’s AIM®.
- Cost-effective pricing: Pay only for successful verifications and save up to 50% compared to competitors.
Category
BiotechnologyNumber of employees
1000.0 – 5000.0
Information sourced from public company data.
ImClone Systems Employment Verification FAQs.
You can verify employment for ImClone Systems employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for ImClone Systems and many other employers.
Yes, Truv offers both employment and income verification services for ImClone Systems employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Jeanes Hospital, Luminex and Caris Life Sciences.
No, the information provided about Truv’s verification services is not an endorsement by the ImClone Systems.
Not the employer you were looking for?
Also verified with Truv
About ImClone Systems
ImClone Systems was an American biopharmaceutical company founded in 1984, specializing in the development and commercialization of oncology treatments. The company gained prominence through its development of Erbitux (cetuximab), a monoclonal antibody used to treat certain types of colorectal cancer and head and neck cancer. The company became publicly traded in 1991 on the NASDAQ exchange. ImClone Systems faced significant controversy in 2001 when its CEO Samuel D. Waksal was involved in an insider trading scandal, along with Martha Stewart, leading to both their convictions and imprisonments. Despite the controversy, ImClone’s scientific achievements continued, particularly with Erbitux, which received FDA approval in 2004. The drug became a significant commercial success, generating substantial revenue through partnerships with Bristol-Myers Squibb in North America and Merck KGaA in Europe. In 2008, Eli Lilly and Company acquired ImClone Systems for $6.5 billion, making it a fully owned subsidiary. The acquisition strengthened Eli Lilly’s oncology portfolio and research capabilities. Under Eli Lilly’s ownership, ImClone’s research facilities continued to operate, focusing on the development of new cancer therapeutics and expanding the applications of existing treatments.
The information on this page is not an endorsement of Truv’s services by ImClone Systems and is meant to be purely informational.
Verify ImClone Systems Employees
Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee. Learn more
Category
BiotechnologyNumber of employees
1000.0 – 5000.0
ImClone Systems Employment Verification FAQ.
You can verify employment for ImClone Systems employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for ImClone Systems and many other employers.
Yes, Truv offers both employment and income verification services for ImClone Systems employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasizes security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Jeanes Hospital, Luminex and Caris Life Sciences.
No, the information provided about Truv’s verification services is not an endorsement by the ImClone Systems.
Yes, Truv provides an option to « Start a verification » directly from this website for ImClone Systems employees and employees of many other organizations.